Physician profile
Michelle Semins
NPI 1578609277
$30,666.98
in general payments reported to CMS, 2019-2025
15 companies · $8,725 in 2025
The $8,725 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,963 · 2020: $3,805 · 2021: $5,022 · 2022: $3,404 · 2023: $3,257 · 2024: $1,491 · 2025: $8,725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $2,252 · Education: $1.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,219.47 |
| Food and Beverage | $2,252.12 |
| Education | $1.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $11,880.00 | 2020-2023 | S~Curve |
| Boston Scientific Corporation | $6,657.41 | 2019-2025 | General - Kidney Stone Disease, Moses 550 D\F\L, General - Therapies |
| Travere Therapeutics, INC. | $4,693.97 | 2019-2023 | Thiola |
| Novo Nordisk Health Care Ag | $3,602.50 | 2025 | |
| Calyxo, INC. | $3,029.38 | 2023-2025 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $205.12 | 2023-2025 | Gemtesa, Orgovyx |
| Cook Medical LLC | $201.31 | 2022-2024 | Litho 150 |
| Coloplast Corp | $123.03 | 2019-2020 | |
| Astellas Pharma US INC | $64.42 | 2019 | |
| Procept Biorobotics Corporation | $54.67 | 2024 | Aquabeam System |
| Pfizer INC. | $45.41 | 2023-2025 | |
| Axonics, INC. | $35.86 | 2023-2024 | Axonics |
| Urogen Pharma, INC. | $32.13 | 2023-2025 | Jelmyto |
| Tolmar, INC. | $22.92 | 2025 | Jatenzo, Eligard |
| Olympus America INC. | $18.85 | 2025 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Semins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.